

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.89799117 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.83368405 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.83368405 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26268112 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.26268112 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26268112 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.26268112 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26268112 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26268112 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04924872 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.64507797 |
| 12 | detection of other organism (GO:0098543) | 4.51382599 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50930563 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44643858 |
| 15 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.43778608 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.40896451 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 4.40896451 |
| 18 | detection of bacterium (GO:0016045) | 4.28276782 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.21343823 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 4.21343823 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.96736937 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 3.95546810 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95340742 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.92828314 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.89053746 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 3.84410268 |
| 27 | leukocyte aggregation (GO:0070486) | 3.81241302 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.75262663 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.73659029 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.72845436 |
| 31 | neutrophil activation (GO:0042119) | 3.46295495 |
| 32 | microglial cell activation (GO:0001774) | 3.44101285 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.44066565 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43610510 |
| 35 | response to host immune response (GO:0052572) | 3.43610510 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42957683 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41820063 |
| 38 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.40527731 |
| 39 | response to interleukin-15 (GO:0070672) | 3.39384226 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38521368 |
| 41 | macrophage activation (GO:0042116) | 3.37450654 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.36732204 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.36732204 |
| 44 | tryptophan catabolic process (GO:0006569) | 3.36732204 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.34166737 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32270568 |
| 47 | response to host (GO:0075136) | 3.32270568 |
| 48 | response to host defenses (GO:0052200) | 3.32270568 |
| 49 | cellular extravasation (GO:0045123) | 3.29363442 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27995522 |
| 51 | regulation of cholesterol homeostasis (GO:2000188) | 3.26888706 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26505067 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26145332 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.22189679 |
| 55 | negative regulation of type 2 immune response (GO:0002829) | 3.20857664 |
| 56 | glyoxylate metabolic process (GO:0046487) | 3.18225431 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.15984014 |
| 58 | signal complex assembly (GO:0007172) | 3.12352620 |
| 59 | cysteine metabolic process (GO:0006534) | 3.09830090 |
| 60 | kynurenine metabolic process (GO:0070189) | 3.09461211 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.09246141 |
| 62 | respiratory burst (GO:0045730) | 3.07515062 |
| 63 | granulocyte activation (GO:0036230) | 3.05348590 |
| 64 | response to peptidoglycan (GO:0032494) | 3.04839676 |
| 65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04815083 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04718538 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.01357296 |
| 68 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.01182165 |
| 69 | positive regulation of Rap GTPase activity (GO:0032854) | 2.99137414 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 2.98475606 |
| 71 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.98134301 |
| 72 | myelin maintenance (GO:0043217) | 2.97708420 |
| 73 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.97468699 |
| 74 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.97298108 |
| 75 | desmosome organization (GO:0002934) | 2.96384443 |
| 76 | skin morphogenesis (GO:0043589) | 2.96160896 |
| 77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93933146 |
| 78 | protein carboxylation (GO:0018214) | 2.93933146 |
| 79 | neutrophil mediated immunity (GO:0002446) | 2.88671452 |
| 80 | regulation of ARF GTPase activity (GO:0032312) | 2.88386186 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87543721 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86774681 |
| 83 | aromatic amino acid family metabolic process (GO:0009072) | 2.85981184 |
| 84 | tyrosine metabolic process (GO:0006570) | 2.84764000 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.82702131 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.82576395 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.81805568 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81357105 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79710770 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79076715 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.78462359 |
| 92 | regulation of regulated secretory pathway (GO:1903305) | 2.77496006 |
| 93 | complement activation, alternative pathway (GO:0006957) | 2.77041848 |
| 94 | hemidesmosome assembly (GO:0031581) | 2.77020008 |
| 95 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.75182449 |
| 96 | apoptotic cell clearance (GO:0043277) | 2.73696271 |
| 97 | regulation of beta-amyloid formation (GO:1902003) | 2.71886530 |
| 98 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.71583660 |
| 99 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.70515391 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70129699 |
| 101 | drug transmembrane transport (GO:0006855) | 2.68425441 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 2.67096066 |
| 103 | response to muramyl dipeptide (GO:0032495) | 2.66074237 |
| 104 | regulation of cellular amide metabolic process (GO:0034248) | 2.65827070 |
| 105 | lysine metabolic process (GO:0006553) | 2.62313207 |
| 106 | lysine catabolic process (GO:0006554) | 2.62313207 |
| 107 | negative regulation of interleukin-12 production (GO:0032695) | 2.61198921 |
| 108 | purine ribonucleotide transport (GO:0015868) | 2.60290233 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59022148 |
| 110 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57684415 |
| 111 | sterol homeostasis (GO:0055092) | 2.54841546 |
| 112 | plasma lipoprotein particle clearance (GO:0034381) | 2.54179494 |
| 113 | cholesterol homeostasis (GO:0042632) | 2.54162273 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.53721336 |
| 115 | amino-acid betaine metabolic process (GO:0006577) | 2.53143234 |
| 116 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.52751563 |
| 117 | response to type I interferon (GO:0034340) | 2.52208787 |
| 118 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51475844 |
| 119 | bile acid metabolic process (GO:0008206) | 2.50795409 |
| 120 | urea metabolic process (GO:0019627) | 2.50709801 |
| 121 | urea cycle (GO:0000050) | 2.50709801 |
| 122 | positive thymic T cell selection (GO:0045059) | 2.50556846 |
| 123 | cell-substrate junction assembly (GO:0007044) | 2.50265244 |
| 124 | regulation of Rap GTPase activity (GO:0032317) | 2.50238811 |
| 125 | actin filament polymerization (GO:0030041) | 2.49825218 |
| 126 | regulation of fibrinolysis (GO:0051917) | 2.49204572 |
| 127 | positive regulation of regulated secretory pathway (GO:1903307) | 2.48736319 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 2.48493424 |
| 129 | serine family amino acid catabolic process (GO:0009071) | 2.48250433 |
| 130 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.48030740 |
| 131 | response to mercury ion (GO:0046689) | 2.47833203 |
| 132 | type I interferon signaling pathway (GO:0060337) | 2.47090357 |
| 133 | cellular response to type I interferon (GO:0071357) | 2.47090357 |
| 134 | bile acid and bile salt transport (GO:0015721) | 2.46979415 |
| 135 | negative regulation of phagocytosis (GO:0050765) | 2.46830754 |
| 136 | urate metabolic process (GO:0046415) | 2.46575031 |
| 137 | bone remodeling (GO:0046849) | 2.46507650 |
| 138 | positive regulation of receptor recycling (GO:0001921) | 2.46267445 |
| 139 | phospholipid homeostasis (GO:0055091) | 2.45796433 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.45777590 |
| 141 | indolalkylamine metabolic process (GO:0006586) | 2.45457324 |
| 142 | fibrinolysis (GO:0042730) | 2.45247434 |
| 143 | low-density lipoprotein particle clearance (GO:0034383) | 2.45205554 |
| 144 | wound healing, spreading of cells (GO:0044319) | 2.44749770 |
| 145 | alpha-linolenic acid metabolic process (GO:0036109) | 2.44717794 |
| 146 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.44633509 |
| 147 | cellular modified amino acid catabolic process (GO:0042219) | 2.43708279 |
| 148 | citrulline biosynthetic process (GO:0019240) | 2.43373918 |
| 149 | wound healing, spreading of epidermal cells (GO:0035313) | 2.43239137 |
| 150 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.42267203 |
| 151 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41812005 |
| 152 | fatty acid beta-oxidation (GO:0006635) | 2.40917841 |
| 153 | cell adhesion mediated by integrin (GO:0033627) | 2.40749046 |
| 154 | acylglycerol homeostasis (GO:0055090) | 2.40586225 |
| 155 | triglyceride homeostasis (GO:0070328) | 2.40586225 |
| 156 | thymic T cell selection (GO:0045061) | 2.40477158 |
| 157 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.39953055 |
| 158 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39949845 |
| 159 | phospholipid scrambling (GO:0017121) | 2.39918132 |
| 160 | regulation of water loss via skin (GO:0033561) | 2.38321512 |
| 161 | positive regulation of osteoblast proliferation (GO:0033690) | 2.38171126 |
| 162 | axon ensheathment in central nervous system (GO:0032291) | 2.37878754 |
| 163 | central nervous system myelination (GO:0022010) | 2.37878754 |
| 164 | regulation of necroptotic process (GO:0060544) | 2.37270783 |
| 165 | dendritic cell migration (GO:0036336) | 2.36924424 |
| 166 | regulation of triglyceride catabolic process (GO:0010896) | 2.36393235 |
| 167 | dendritic cell chemotaxis (GO:0002407) | 2.35935064 |
| 168 | regulation of hippo signaling (GO:0035330) | 2.35921183 |
| 169 | nitrogen cycle metabolic process (GO:0071941) | 2.35812256 |
| 170 | mannose metabolic process (GO:0006013) | 2.35540579 |
| 171 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.35090683 |
| 172 | acetyl-CoA metabolic process (GO:0006084) | 2.34492442 |
| 173 | regulation of protein activation cascade (GO:2000257) | 2.34129592 |
| 174 | coenzyme catabolic process (GO:0009109) | 2.33683730 |
| 175 | response to hepatocyte growth factor (GO:0035728) | 2.33328836 |
| 176 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.33328836 |
| 177 | lipoprotein metabolic process (GO:0042157) | 2.32626274 |
| 178 | fatty acid oxidation (GO:0019395) | 2.32572549 |
| 179 | bile acid biosynthetic process (GO:0006699) | 2.32180592 |
| 180 | cellular biogenic amine catabolic process (GO:0042402) | 2.31261600 |
| 181 | amine catabolic process (GO:0009310) | 2.31261600 |
| 182 | proline metabolic process (GO:0006560) | 2.30845638 |
| 183 | diterpenoid biosynthetic process (GO:0016102) | 2.30675797 |
| 184 | renal filtration (GO:0097205) | 2.29780733 |
| 185 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.29582736 |
| 186 | regulation of plasminogen activation (GO:0010755) | 2.29448127 |
| 187 | biotin metabolic process (GO:0006768) | 2.26520754 |
| 188 | lipid oxidation (GO:0034440) | 2.26223684 |
| 189 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.25142128 |
| 190 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.25142128 |
| 191 | regulation of integrin activation (GO:0033623) | 2.25140889 |
| 192 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.24933607 |
| 193 | regulation of complement activation (GO:0030449) | 2.24212141 |
| 194 | valine metabolic process (GO:0006573) | 2.24115767 |
| 195 | protein localization to endosome (GO:0036010) | 2.23098198 |
| 196 | protein-lipid complex assembly (GO:0065005) | 2.22416383 |
| 197 | alpha-amino acid catabolic process (GO:1901606) | 2.21894996 |
| 198 | negative regulation of lipase activity (GO:0060192) | 2.21390160 |
| 199 | fatty acid elongation (GO:0030497) | 2.21111357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.71321730 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.26703142 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11840956 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63705261 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.59094229 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.21478832 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71723335 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.67027800 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.55751217 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.39663865 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30198047 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28467971 |
| 13 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27985048 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18281452 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17479737 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17463339 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.15020014 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10889072 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10394565 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.07719712 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.05117094 |
| 22 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.01999728 |
| 23 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.00119655 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95333803 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94804925 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94678500 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87166050 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.83025223 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.82804201 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78731595 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76672709 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75937997 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75502890 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.73573683 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72317056 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72092907 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70954042 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69617658 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66431835 |
| 40 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64977829 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.61949881 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59536417 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58959415 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58859527 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56375183 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55584666 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54339916 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54281584 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54042778 |
| 50 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.53280489 |
| 51 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.53029620 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50775417 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.50346279 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49943521 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49312299 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48807664 |
| 57 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47785220 |
| 58 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.46932217 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46315965 |
| 60 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.45913991 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43404023 |
| 62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43258444 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41470915 |
| 64 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41293134 |
| 65 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.40429385 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.38165811 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36329588 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34351785 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34310238 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.34041641 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33939636 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.33169838 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31139579 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30515667 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29825602 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29555540 |
| 77 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29371573 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28665229 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28658632 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27054334 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26985052 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26155437 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24909177 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24497744 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24280186 |
| 86 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23532747 |
| 87 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23070011 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22012618 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22000837 |
| 90 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21489416 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20378163 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20378163 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19423357 |
| 94 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19035828 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.17700109 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16361193 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15714641 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15151582 |
| 99 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14476657 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14153932 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14067800 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13382871 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13365862 |
| 104 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.12116430 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12038129 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11047914 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10519216 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 1.09554292 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09503541 |
| 110 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07461229 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06070916 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05695485 |
| 113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04197207 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03645438 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03370119 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03370119 |
| 117 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02681172 |
| 118 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01988337 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01839825 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01703316 |
| 121 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00466923 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00451779 |
| 123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99720117 |
| 124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99640880 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99157779 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98932958 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97740317 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97514315 |
| 129 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97474364 |
| 130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97380784 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97243582 |
| 132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96903693 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96571334 |
| 134 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95226147 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94155222 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93810362 |
| 137 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92976580 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92876558 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90550487 |
| 140 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90496855 |
| 141 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89394401 |
| 142 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89023466 |
| 143 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.88861083 |
| 144 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88842712 |
| 145 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88465007 |
| 146 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88099024 |
| 147 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87290117 |
| 148 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86864174 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86068883 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85334869 |
| 151 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85271880 |
| 152 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.84190986 |
| 153 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.84190986 |
| 154 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.84190986 |
| 155 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83782546 |
| 156 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83682455 |
| 157 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83388866 |
| 158 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81908233 |
| 159 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81908233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.06404223 |
| 2 | MP0005360_urolithiasis | 3.74647773 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.51898601 |
| 4 | MP0005365_abnormal_bile_salt | 3.47145898 |
| 5 | MP0003436_decreased_susceptibility_to | 3.33444378 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.00053764 |
| 7 | MP0008260_abnormal_autophagy | 2.93873086 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.87180444 |
| 9 | MP0003252_abnormal_bile_duct | 2.72789530 |
| 10 | MP0003303_peritoneal_inflammation | 2.72333063 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.43373022 |
| 12 | MP0003878_abnormal_ear_physiology | 2.18941089 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.18941089 |
| 14 | MP0002419_abnormal_innate_immunity | 2.18702143 |
| 15 | MP0009840_abnormal_foam_cell | 2.17041241 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.16058260 |
| 17 | MP0005275_abnormal_skin_tensile | 2.14605823 |
| 18 | MP0003195_calcinosis | 2.07494739 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.00008498 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.99829865 |
| 21 | MP0005025_abnormal_response_to | 1.94326926 |
| 22 | MP0001851_eye_inflammation | 1.91485456 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.86079152 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.84598141 |
| 25 | MP0002060_abnormal_skin_morphology | 1.83349099 |
| 26 | MP0005409_darkened_coat_color | 1.81581041 |
| 27 | MP0005451_abnormal_body_composition | 1.77984074 |
| 28 | MP0005332_abnormal_amino_acid | 1.77419479 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.76985271 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.76641792 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.74747059 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.72861067 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.72065738 |
| 34 | MP0001800_abnormal_humoral_immune | 1.69592252 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67820275 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.66758190 |
| 37 | MP0000579_abnormal_nail_morphology | 1.63767215 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.62556550 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.61714659 |
| 40 | MP0003329_amyloid_beta_deposits | 1.59158210 |
| 41 | MP0006082_CNS_inflammation | 1.56314964 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.56080120 |
| 43 | MP0000685_abnormal_immune_system | 1.56071414 |
| 44 | MP0001819_abnormal_immune_cell | 1.56047252 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.55682508 |
| 46 | MP0004858_abnormal_nervous_system | 1.55612301 |
| 47 | MP0005670_abnormal_white_adipose | 1.55267874 |
| 48 | MP0002796_impaired_skin_barrier | 1.53270313 |
| 49 | MP0000383_abnormal_hair_follicle | 1.53184657 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.50699311 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.50487648 |
| 52 | MP0002723_abnormal_immune_serum | 1.49891811 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.49126245 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.47545397 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.46543705 |
| 56 | MP0003828_pulmonary_edema | 1.46519230 |
| 57 | MP0004272_abnormal_basement_membrane | 1.42027117 |
| 58 | MP0003866_abnormal_defecation | 1.40968422 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.40839756 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.40839341 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.40714401 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.37944303 |
| 63 | MP0000566_synostosis | 1.36675887 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.36600816 |
| 65 | MP0001790_abnormal_immune_system | 1.36383581 |
| 66 | MP0005387_immune_system_phenotype | 1.36383581 |
| 67 | MP0000920_abnormal_myelination | 1.36280879 |
| 68 | MP0005023_abnormal_wound_healing | 1.34465568 |
| 69 | MP0003045_fibrosis | 1.34363474 |
| 70 | MP0010329_abnormal_lipoprotein_level | 1.33140530 |
| 71 | MP0000462_abnormal_digestive_system | 1.32492880 |
| 72 | MP0005171_absent_coat_pigmentation | 1.31132208 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 1.30430200 |
| 74 | MP0005408_hypopigmentation | 1.29167031 |
| 75 | MP0002132_abnormal_respiratory_system | 1.28961322 |
| 76 | MP0000858_altered_metastatic_potential | 1.26356384 |
| 77 | MP0004130_abnormal_muscle_cell | 1.25902378 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.24514496 |
| 79 | MP0000609_abnormal_liver_physiology | 1.23366524 |
| 80 | MP0009785_altered_susceptibility_to | 1.23004670 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 1.21561227 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 1.19678455 |
| 83 | MP0001849_ear_inflammation | 1.19391576 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.19274466 |
| 85 | MP0002254_reproductive_system_inflammat | 1.17899244 |
| 86 | MP0002168_other_aberrant_phenotype | 1.15588495 |
| 87 | MP0004883_abnormal_blood_vessel | 1.13898065 |
| 88 | MP0004510_myositis | 1.13559969 |
| 89 | MP0002405_respiratory_system_inflammati | 1.11985099 |
| 90 | MP0002928_abnormal_bile_duct | 1.11166701 |
| 91 | MP0010030_abnormal_orbit_morphology | 1.09358019 |
| 92 | MP0003075_altered_response_to | 1.08807997 |
| 93 | MP0000377_abnormal_hair_follicle | 1.07989173 |
| 94 | MP0001958_emphysema | 1.07983646 |
| 95 | MP0005666_abnormal_adipose_tissue | 1.07948485 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 1.07638647 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.07227682 |
| 98 | MP0000716_abnormal_immune_system | 1.05960494 |
| 99 | MP0005464_abnormal_platelet_physiology | 1.04846242 |
| 100 | MP0005671_abnormal_response_to | 1.03281444 |
| 101 | MP0005501_abnormal_skin_physiology | 1.03230695 |
| 102 | MP0004947_skin_inflammation | 1.01787070 |
| 103 | MP0004043_abnormal_pH_regulation | 1.00549089 |
| 104 | MP0000470_abnormal_stomach_morphology | 0.99750849 |
| 105 | MP0003690_abnormal_glial_cell | 0.98889935 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.98473342 |
| 107 | MP0001243_abnormal_dermal_layer | 0.96604017 |
| 108 | MP0003868_abnormal_feces_composition | 0.96570411 |
| 109 | MP0005083_abnormal_biliary_tract | 0.96079562 |
| 110 | MP0000762_abnormal_tongue_morphology | 0.95601656 |
| 111 | MP0002398_abnormal_bone_marrow | 0.95574323 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.93190591 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.92922460 |
| 114 | MP0002133_abnormal_respiratory_system | 0.92054854 |
| 115 | MP0005388_respiratory_system_phenotype | 0.92054854 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.89427965 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.87532649 |
| 118 | MP0005164_abnormal_response_to | 0.87271144 |
| 119 | MP0005166_decreased_susceptibility_to | 0.87109176 |
| 120 | MP0004381_abnormal_hair_follicle | 0.87068775 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.87031770 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.86948989 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.86886046 |
| 124 | MP0001346_abnormal_lacrimal_gland | 0.86809077 |
| 125 | MP0010352_gastrointestinal_tract_polyps | 0.86008450 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.85138964 |
| 127 | MP0001756_abnormal_urination | 0.84632035 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.83708255 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.83142201 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.81918308 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.81803020 |
| 132 | MP0005310_abnormal_salivary_gland | 0.80459176 |
| 133 | MP0003279_aneurysm | 0.79927563 |
| 134 | MP0000613_abnormal_salivary_gland | 0.79069147 |
| 135 | MP0003879_abnormal_hair_cell | 0.78666587 |
| 136 | MP0008874_decreased_physiological_sensi | 0.78631281 |
| 137 | MP0005508_abnormal_skeleton_morphology | 0.78233771 |
| 138 | MP0009278_abnormal_bone_marrow | 0.76529200 |
| 139 | MP0003091_abnormal_cell_migration | 0.76168095 |
| 140 | MP0000598_abnormal_liver_morphology | 0.74844929 |
| 141 | MP0000003_abnormal_adipose_tissue | 0.74574686 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.74149973 |
| 143 | MP0000733_abnormal_muscle_development | 0.72663275 |
| 144 | MP0000427_abnormal_hair_cycle | 0.72552886 |
| 145 | MP0000678_abnormal_parathyroid_gland | 0.72336227 |
| 146 | MP0002295_abnormal_pulmonary_circulatio | 0.72224147 |
| 147 | MP0002722_abnormal_immune_system | 0.71765500 |
| 148 | MP0002429_abnormal_blood_cell | 0.71373596 |
| 149 | MP0005395_other_phenotype | 0.71200008 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.67700292 |
| 151 | MP0009333_abnormal_splenocyte_physiolog | 0.67119917 |
| 152 | MP0009931_abnormal_skin_appearance | 0.65102741 |
| 153 | MP0006054_spinal_hemorrhage | 0.64414311 |
| 154 | MP0003172_abnormal_lysosome_physiology | 0.63998407 |
| 155 | MP0010771_integument_phenotype | 0.62601364 |
| 156 | MP0002697_abnormal_eye_size | 0.62262206 |
| 157 | MP0000537_abnormal_urethra_morphology | 0.62049584 |
| 158 | MP0001881_abnormal_mammary_gland | 0.60959189 |
| 159 | MP0000516_abnormal_urinary_system | 0.60716308 |
| 160 | MP0005367_renal/urinary_system_phenotyp | 0.60716308 |
| 161 | MP0000627_abnormal_mammary_gland | 0.59978709 |
| 162 | MP0000767_abnormal_smooth_muscle | 0.59849706 |
| 163 | MP0002092_abnormal_eye_morphology | 0.58865425 |
| 164 | MP0004885_abnormal_endolymph | 0.58660586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.73915178 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.46676155 |
| 3 | Myositis (HP:0100614) | 4.38734537 |
| 4 | Orchitis (HP:0100796) | 4.31112885 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.28998288 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.79228552 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.78198670 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.77098762 |
| 9 | Optic neuritis (HP:0100653) | 3.77098762 |
| 10 | Premature rupture of membranes (HP:0001788) | 3.65578778 |
| 11 | Increased IgE level (HP:0003212) | 3.60865108 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59577382 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.42975255 |
| 14 | Gingivitis (HP:0000230) | 3.42024706 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.39980131 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.37782395 |
| 17 | Xanthomatosis (HP:0000991) | 3.21175708 |
| 18 | Thick nail (HP:0001805) | 3.16542330 |
| 19 | Stomatitis (HP:0010280) | 3.15731054 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.14162887 |
| 21 | Abnormality of nail color (HP:0100643) | 3.03399248 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.00511902 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 2.98017793 |
| 24 | Turricephaly (HP:0000262) | 2.94021072 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.92535738 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86743511 |
| 27 | Atrophic scars (HP:0001075) | 2.84624973 |
| 28 | Hypochromic anemia (HP:0001931) | 2.83375629 |
| 29 | Ulnar bowing (HP:0003031) | 2.81848079 |
| 30 | Myocardial infarction (HP:0001658) | 2.80147307 |
| 31 | Alopecia of scalp (HP:0002293) | 2.78893206 |
| 32 | Hydroxyprolinuria (HP:0003080) | 2.76388403 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.76388403 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75282927 |
| 35 | Malnutrition (HP:0004395) | 2.74272032 |
| 36 | Vascular calcification (HP:0004934) | 2.73770862 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.72657586 |
| 38 | Parakeratosis (HP:0001036) | 2.71362436 |
| 39 | Cardiovascular calcification (HP:0011915) | 2.67393983 |
| 40 | Plantar hyperkeratosis (HP:0007556) | 2.67231934 |
| 41 | Focal segmental glomerulosclerosis (HP:0000097) | 2.59336963 |
| 42 | Subacute progressive viral hepatitis (HP:0006572) | 2.56834758 |
| 43 | Joint hemorrhage (HP:0005261) | 2.55967405 |
| 44 | Amyloidosis (HP:0011034) | 2.55630672 |
| 45 | Axonal loss (HP:0003447) | 2.54491587 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.53689452 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 2.53524344 |
| 48 | Recurrent skin infections (HP:0001581) | 2.51508827 |
| 49 | Abnormality of the salivary glands (HP:0010286) | 2.46839402 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.44159108 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43797458 |
| 52 | Urticaria (HP:0001025) | 2.43092032 |
| 53 | Broad face (HP:0000283) | 2.41295503 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.39376867 |
| 55 | Cheilitis (HP:0100825) | 2.38092823 |
| 56 | Episodic fever (HP:0001954) | 2.36995006 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.34750703 |
| 58 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.34491858 |
| 59 | Cellulitis (HP:0100658) | 2.30486465 |
| 60 | Complement deficiency (HP:0004431) | 2.30131397 |
| 61 | Metabolic alkalosis (HP:0200114) | 2.28949229 |
| 62 | Hyperglycinuria (HP:0003108) | 2.28586603 |
| 63 | Slow saccadic eye movements (HP:0000514) | 2.25840943 |
| 64 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.25528634 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24572244 |
| 66 | Metaphyseal cupping (HP:0003021) | 2.23620026 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.23484323 |
| 68 | Gingival bleeding (HP:0000225) | 2.23360619 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.22834797 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.22789356 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.22789356 |
| 72 | Glomerulosclerosis (HP:0000096) | 2.22735771 |
| 73 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21274451 |
| 74 | Abnormality of chloride homeostasis (HP:0011422) | 2.19605757 |
| 75 | Peritonitis (HP:0002586) | 2.18710206 |
| 76 | Obstructive lung disease (HP:0006536) | 2.17517725 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17517725 |
| 78 | Nail dystrophy (HP:0008404) | 2.17493315 |
| 79 | Palmoplantar hyperkeratosis (HP:0000972) | 2.17289801 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.16910089 |
| 81 | Hypokalemic alkalosis (HP:0001949) | 2.15775727 |
| 82 | Fat malabsorption (HP:0002630) | 2.15309415 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.12945379 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12498962 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12498962 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12498962 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12221425 |
| 88 | Epidermoid cyst (HP:0200040) | 2.11833374 |
| 89 | Peripheral demyelination (HP:0011096) | 2.11506643 |
| 90 | Abnormal blistering of the skin (HP:0008066) | 2.11437824 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.10681416 |
| 92 | Difficulty running (HP:0009046) | 2.10548006 |
| 93 | Prolonged partial thromboplastin time (HP:0003645) | 2.10453592 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.10323831 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10323831 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.09601732 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.09465716 |
| 98 | Hyperactive renin-angiotensin system (HP:0000841) | 2.09143602 |
| 99 | Fragile nails (HP:0001808) | 2.09126366 |
| 100 | Gout (HP:0001997) | 2.09036647 |
| 101 | Premature skin wrinkling (HP:0100678) | 2.08528589 |
| 102 | Meningitis (HP:0001287) | 2.07916565 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.06683486 |
| 104 | Elevated alkaline phosphatase (HP:0003155) | 2.06429526 |
| 105 | Hypoplasia of dental enamel (HP:0006297) | 2.06032135 |
| 106 | Hyperglycemia (HP:0003074) | 2.04336247 |
| 107 | Chest pain (HP:0100749) | 2.03729748 |
| 108 | Ketosis (HP:0001946) | 2.03164078 |
| 109 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02942291 |
| 110 | Symptomatic seizures (HP:0011145) | 2.02362650 |
| 111 | Abnormality of the fingertips (HP:0001211) | 2.02341388 |
| 112 | Alkalosis (HP:0001948) | 2.01903674 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00334803 |
| 114 | Aortic dissection (HP:0002647) | 1.98947864 |
| 115 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98780837 |
| 116 | Widely patent fontanelles and sutures (HP:0004492) | 1.98639009 |
| 117 | Polygenic inheritance (HP:0010982) | 1.98060839 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97440251 |
| 119 | Rickets (HP:0002748) | 1.97376950 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 1.97162280 |
| 121 | Bronchomalacia (HP:0002780) | 1.97086893 |
| 122 | Mitral stenosis (HP:0001718) | 1.94841998 |
| 123 | Shallow orbits (HP:0000586) | 1.93583177 |
| 124 | Palmar hyperkeratosis (HP:0010765) | 1.93095532 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.92809057 |
| 126 | Cerebral inclusion bodies (HP:0100314) | 1.92654857 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 1.91431276 |
| 128 | Premature loss of primary teeth (HP:0006323) | 1.91113213 |
| 129 | Abnormal vertebral ossification (HP:0100569) | 1.90630000 |
| 130 | Encephalitis (HP:0002383) | 1.90571791 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.90494794 |
| 132 | Hypomagnesemia (HP:0002917) | 1.89163792 |
| 133 | Systemic lupus erythematosus (HP:0002725) | 1.89076624 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.88405756 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.88312634 |
| 136 | Abnormality of complement system (HP:0005339) | 1.87817894 |
| 137 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87417369 |
| 138 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87188024 |
| 139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86345576 |
| 140 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86202556 |
| 141 | Tibial bowing (HP:0002982) | 1.85683424 |
| 142 | Esophageal varix (HP:0002040) | 1.85363243 |
| 143 | Abnormality of incisor morphology (HP:0011063) | 1.85215509 |
| 144 | Anorexia (HP:0002039) | 1.85083426 |
| 145 | Increased circulating renin level (HP:0000848) | 1.84432168 |
| 146 | Pulmonary embolism (HP:0002204) | 1.83805597 |
| 147 | Menorrhagia (HP:0000132) | 1.83074001 |
| 148 | Postural instability (HP:0002172) | 1.82518238 |
| 149 | Osteolytic defects of the hand bones (HP:0009699) | 1.81504378 |
| 150 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81504378 |
| 151 | Coronal craniosynostosis (HP:0004440) | 1.81386089 |
| 152 | Vasculitis (HP:0002633) | 1.81193056 |
| 153 | Acne (HP:0001061) | 1.80577806 |
| 154 | Cervical subluxation (HP:0003308) | 1.80314683 |
| 155 | Ankle clonus (HP:0011448) | 1.78648811 |
| 156 | Arterial thrombosis (HP:0004420) | 1.78399470 |
| 157 | Protrusio acetabuli (HP:0003179) | 1.78308018 |
| 158 | Milia (HP:0001056) | 1.77994728 |
| 159 | Abnormal platelet volume (HP:0011876) | 1.77400466 |
| 160 | Onion bulb formation (HP:0003383) | 1.77254442 |
| 161 | Ketoacidosis (HP:0001993) | 1.77152648 |
| 162 | Hemoptysis (HP:0002105) | 1.75699670 |
| 163 | Skin ulcer (HP:0200042) | 1.75545350 |
| 164 | Vacuolated lymphocytes (HP:0001922) | 1.75416664 |
| 165 | Onycholysis (HP:0001806) | 1.74329542 |
| 166 | Ankyloglossia (HP:0010296) | 1.73686626 |
| 167 | Pustule (HP:0200039) | 1.73602585 |
| 168 | Abdominal distention (HP:0003270) | 1.73587901 |
| 169 | Bowed forearm bones (HP:0003956) | 1.73585897 |
| 170 | Bowing of the arm (HP:0006488) | 1.73585897 |
| 171 | Hypoalphalipoproteinemia (HP:0003233) | 1.72349644 |
| 172 | Fragile skin (HP:0001030) | 1.72252316 |
| 173 | Hyperglycinemia (HP:0002154) | 1.71483410 |
| 174 | Tetany (HP:0001281) | 1.71100949 |
| 175 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.70737757 |
| 176 | Germ cell neoplasia (HP:0100728) | 1.70691834 |
| 177 | Hypoplasia of the iris (HP:0007676) | 1.69745763 |
| 178 | Thin bony cortex (HP:0002753) | 1.69582547 |
| 179 | Muscle fiber splitting (HP:0003555) | 1.67842185 |
| 180 | Sepsis (HP:0100806) | 1.67507122 |
| 181 | Interstitial pulmonary disease (HP:0006530) | 1.66549209 |
| 182 | Lip pit (HP:0100267) | 1.66433060 |
| 183 | Pili torti (HP:0003777) | 1.64814429 |
| 184 | Periodontitis (HP:0000704) | 1.64741335 |
| 185 | Increased connective tissue (HP:0009025) | 1.62214117 |
| 186 | Amelogenesis imperfecta (HP:0000705) | 1.61508573 |
| 187 | Diplopia (HP:0000651) | 1.60756951 |
| 188 | Abnormality of binocular vision (HP:0011514) | 1.60756951 |
| 189 | Micronodular cirrhosis (HP:0001413) | 1.60519530 |
| 190 | Ventricular tachycardia (HP:0004756) | 1.60386712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.28297170 |
| 2 | RIPK4 | 3.33909127 |
| 3 | LATS1 | 3.31078219 |
| 4 | EPHB1 | 2.91781124 |
| 5 | TAOK3 | 2.53245416 |
| 6 | MAPK15 | 2.48580292 |
| 7 | ERN1 | 2.32153054 |
| 8 | STK39 | 2.20979446 |
| 9 | INSRR | 2.18909025 |
| 10 | TRPM7 | 2.18890626 |
| 11 | MET | 2.12437053 |
| 12 | OXSR1 | 2.09195632 |
| 13 | MAP2K3 | 2.07339432 |
| 14 | MAP4K1 | 1.99964927 |
| 15 | SIK1 | 1.94166624 |
| 16 | TAOK1 | 1.91653019 |
| 17 | STK38L | 1.86140195 |
| 18 | WNK4 | 1.81965545 |
| 19 | GRK6 | 1.71561768 |
| 20 | BMX | 1.70766255 |
| 21 | KSR2 | 1.70536445 |
| 22 | TRIB3 | 1.66530673 |
| 23 | TYK2 | 1.64250935 |
| 24 | CDK12 | 1.62416103 |
| 25 | DDR2 | 1.59864182 |
| 26 | FES | 1.56068818 |
| 27 | PTK2 | 1.56012448 |
| 28 | TTN | 1.55905755 |
| 29 | MAP3K2 | 1.55839040 |
| 30 | MST1R | 1.55799918 |
| 31 | SMG1 | 1.55783915 |
| 32 | ZAP70 | 1.47689560 |
| 33 | PRPF4B | 1.46662112 |
| 34 | MAP3K1 | 1.45962185 |
| 35 | RIPK1 | 1.39218172 |
| 36 | STK3 | 1.36519329 |
| 37 | PKN1 | 1.36443582 |
| 38 | ICK | 1.35472891 |
| 39 | STK10 | 1.35130714 |
| 40 | MAP3K11 | 1.33951684 |
| 41 | STK38 | 1.33869436 |
| 42 | PTK6 | 1.33096359 |
| 43 | WNK1 | 1.30686707 |
| 44 | CSK | 1.29532353 |
| 45 | HCK | 1.26420412 |
| 46 | MAP3K7 | 1.20976252 |
| 47 | CAMK1D | 1.20679430 |
| 48 | BTK | 1.20368451 |
| 49 | MAP3K9 | 1.19997772 |
| 50 | SGK3 | 1.18532190 |
| 51 | ERBB4 | 1.18488216 |
| 52 | MAP3K14 | 1.17725395 |
| 53 | PDGFRA | 1.16938971 |
| 54 | FGFR4 | 1.14158457 |
| 55 | BCKDK | 1.10285507 |
| 56 | MTOR | 1.06302530 |
| 57 | STK11 | 1.04101869 |
| 58 | DAPK2 | 1.03816143 |
| 59 | YES1 | 1.02949997 |
| 60 | MARK3 | 0.99562696 |
| 61 | MAP2K2 | 0.98598480 |
| 62 | IRAK2 | 0.98056302 |
| 63 | MAP3K3 | 0.96603454 |
| 64 | GSK3A | 0.94739337 |
| 65 | PDPK1 | 0.94457942 |
| 66 | JAK3 | 0.93940973 |
| 67 | JAK2 | 0.93346355 |
| 68 | FLT3 | 0.90632257 |
| 69 | IRAK3 | 0.90606786 |
| 70 | PTK2B | 0.87545055 |
| 71 | PIK3CG | 0.87535624 |
| 72 | SGK2 | 0.87193098 |
| 73 | PDK1 | 0.87160357 |
| 74 | EPHA3 | 0.84264144 |
| 75 | PAK4 | 0.84215570 |
| 76 | CDC42BPA | 0.82859900 |
| 77 | IKBKE | 0.82808917 |
| 78 | PRKD2 | 0.82563044 |
| 79 | FGFR3 | 0.81780205 |
| 80 | RET | 0.81748176 |
| 81 | PRKAA2 | 0.80505988 |
| 82 | FRK | 0.78627534 |
| 83 | BRSK2 | 0.76885493 |
| 84 | CAMK1G | 0.73452964 |
| 85 | NEK9 | 0.72238826 |
| 86 | PIK3CA | 0.71837353 |
| 87 | IRAK1 | 0.71347822 |
| 88 | PRKD1 | 0.70781298 |
| 89 | LCK | 0.70749320 |
| 90 | FER | 0.70737495 |
| 91 | DYRK1B | 0.70510519 |
| 92 | RPS6KA2 | 0.70155507 |
| 93 | PDGFRB | 0.69720062 |
| 94 | PRKD3 | 0.69626566 |
| 95 | NUAK1 | 0.69306130 |
| 96 | PAK2 | 0.68918005 |
| 97 | TGFBR2 | 0.68474285 |
| 98 | SIK3 | 0.66296805 |
| 99 | MAPK11 | 0.66013429 |
| 100 | FYN | 0.64689356 |
| 101 | CAMKK1 | 0.64593188 |
| 102 | MARK2 | 0.62504450 |
| 103 | PRKG2 | 0.61510140 |
| 104 | MAP2K6 | 0.60870086 |
| 105 | RPS6KL1 | 0.60460635 |
| 106 | RPS6KC1 | 0.60460635 |
| 107 | MAP2K4 | 0.59912161 |
| 108 | KSR1 | 0.59419387 |
| 109 | DMPK | 0.58707576 |
| 110 | PRKCZ | 0.58604368 |
| 111 | NEK6 | 0.58513633 |
| 112 | CHUK | 0.58412166 |
| 113 | SYK | 0.57690303 |
| 114 | SIK2 | 0.57327476 |
| 115 | UHMK1 | 0.57172455 |
| 116 | CDK6 | 0.57089294 |
| 117 | HIPK2 | 0.56418838 |
| 118 | MST4 | 0.56326715 |
| 119 | MELK | 0.56242352 |
| 120 | FGFR2 | 0.54208378 |
| 121 | RPS6KA6 | 0.54196614 |
| 122 | PRKCH | 0.54025681 |
| 123 | IKBKB | 0.53508456 |
| 124 | JAK1 | 0.50996572 |
| 125 | NTRK3 | 0.50781583 |
| 126 | SGK494 | 0.49955991 |
| 127 | SGK223 | 0.49955991 |
| 128 | LATS2 | 0.49546602 |
| 129 | MAPK12 | 0.49298512 |
| 130 | LYN | 0.49296740 |
| 131 | WNK3 | 0.48940413 |
| 132 | TBK1 | 0.48819348 |
| 133 | LRRK2 | 0.47879363 |
| 134 | ABL1 | 0.47764622 |
| 135 | STK24 | 0.47488686 |
| 136 | BLK | 0.47223829 |
| 137 | ERBB2 | 0.46437418 |
| 138 | CAMK2D | 0.46325961 |
| 139 | MAPKAPK2 | 0.45923544 |
| 140 | PRKAA1 | 0.45345336 |
| 141 | RAF1 | 0.45167145 |
| 142 | MATK | 0.44891171 |
| 143 | CAMK2G | 0.40755491 |
| 144 | FGR | 0.40735352 |
| 145 | IRAK4 | 0.39013362 |
| 146 | MAP3K6 | 0.38552994 |
| 147 | AKT3 | 0.38327055 |
| 148 | MAPK1 | 0.37367117 |
| 149 | PAK3 | 0.37237594 |
| 150 | TNK2 | 0.36964910 |
| 151 | PKN2 | 0.35822554 |
| 152 | MAP3K13 | 0.35658977 |
| 153 | MAPK7 | 0.35241150 |
| 154 | ITK | 0.35238406 |
| 155 | PINK1 | 0.34842486 |
| 156 | CSF1R | 0.34638498 |
| 157 | MAPKAPK5 | 0.34601438 |
| 158 | RPS6KB2 | 0.34250059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49848033 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37431777 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28422087 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.20501334 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09536122 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09211910 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08572628 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06214391 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04770809 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01834092 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.97012485 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.94557018 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90897318 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88048650 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82910565 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81927916 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80689771 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.74065149 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73457031 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67931858 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65958903 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.64715038 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61812392 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.61640797 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57998849 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56846882 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54361219 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.53518593 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53237696 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52926198 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.50969837 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49990578 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43918812 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.43490183 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43467228 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42850026 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42499714 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42457435 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42450160 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39795460 |
| 41 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.35780925 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34295562 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33174733 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31328068 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29570296 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28904116 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28284034 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27948224 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27712263 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.26332724 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.24727788 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.23492129 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23072433 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.22999385 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22924314 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20888535 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20402762 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18249204 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17224927 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16963737 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16842415 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16638120 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.15347134 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14086369 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13299266 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 1.12853959 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11599215 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10490279 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10440990 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08884388 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07303568 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06392354 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 1.05933048 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 1.04428344 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03740998 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 1.03514758 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01701111 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00460790 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99623278 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99537742 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.97881897 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97566622 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97104586 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.96646627 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93044632 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91776526 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.91691599 |
| 88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90997052 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90296391 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90262891 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89896551 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89864234 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89700564 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89578798 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89162243 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88885936 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88777839 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88084543 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88054894 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87934031 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86959837 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85237240 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85103533 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84088273 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83318449 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81805230 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81512339 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.80255433 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79727150 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79178406 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78504114 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77986503 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.77682090 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.77559008 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76966015 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74715608 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74478744 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74145832 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74140146 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.72720399 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72706659 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71679493 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.70868336 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70598050 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.70162319 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69625387 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.69385405 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66409579 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66033743 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65515189 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65242564 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65192628 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63635682 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63606931 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63111210 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62968364 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62852309 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62299003 |
| 139 | Axon guidance_Homo sapiens_hsa04360 | 0.61012132 |
| 140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60214307 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.60035273 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.59832109 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.59748961 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.58742166 |
| 145 | Long-term depression_Homo sapiens_hsa04730 | 0.57784172 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57623524 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57207528 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56479940 |
| 149 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55542689 |
| 150 | Renin secretion_Homo sapiens_hsa04924 | 0.55464750 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.54605151 |
| 152 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53493356 |
| 153 | Malaria_Homo sapiens_hsa05144 | 0.52812008 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.52263777 |
| 155 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51908440 |
| 156 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51305178 |
| 157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50663124 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49106247 |
| 159 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48947509 |
| 160 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48284220 |
| 161 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48171385 |
| 162 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46493342 |
| 163 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45282949 |
| 164 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44854932 |
| 165 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43773651 |
| 166 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43363822 |
| 167 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42586164 |
| 168 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42515019 |
| 169 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42193386 |
| 170 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41991866 |
| 171 | Prostate cancer_Homo sapiens_hsa05215 | 0.39283409 |
| 172 | Hepatitis C_Homo sapiens_hsa05160 | 0.39231969 |
| 173 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38134133 |
| 174 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36068866 |
| 175 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36009125 |
| 176 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35873637 |
| 177 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35143312 |
| 178 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35074032 |
| 179 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34546334 |
| 180 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32926957 |

